Healthy Skepticism Library item: 4424

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Silverman M, Lydecker M, Lee PR.
Bad medicine: the prescription drug industry in the Third World
Stanford University Press 1992

Abstract:

Most multinational firms are more willing to restrict claims of efficacy for their products to the scientifically justifiable and appear more willing to divulge the major hazards of their products. However, domestic firms have not changed their policies and practices. An additional problem is the willingness of domestic companies to promote drugs that were removed from the market by multinational corporations. The book also discusses the approach of Medical Lobby for Appropriate Marketing in trying to improve promotion.

Keywords:
*analytic survey/developed countries/developing countries/commercial compendia/ domestic companies/ safety & risk information/ Medical Lobby for Appropriate Marketing/ MaLAM/EVALUATION OF PROMOTION: COMMERCIAL DRUG COMPENDIA/EVALUATION OF PROMOTION: COMPARISON BETWEEN DEVELOPING AND DEVELOPED COUNTRIES/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES